लोड हो रहा है...
ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan
Irinotecan is a key drug for patients with advanced and recurrent colorectal carcinoma. However, the efficacy of irinotecan is not sufficient; partly, as there is no useful marker to predict chemosensitivity to the drug. The aim of the present study was to evaluate whether the expression levels of a...
में बचाया:
| में प्रकाशित: | Oncol Lett |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
D.A. Spandidos
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038226/ https://ncbi.nlm.nih.gov/pubmed/27698852 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2016.4937 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|